TheraRadar
← Back
Data updated: Mar 29, 2026

NE RX PHARMA

CardiovascularGastroenterologyNeurology
Generics

NE RX PHARMA is a generic drug manufacturer focused on Cardiovascular, Gastroenterology, Neurology.

2022
Since
5
Drugs
-
Trials
33
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

ACETAZOLAMIDE 2026-01-12
Labeling
VARENICLINE TARTRATE 2026-01-09
ACETAZOLAMIDE 2026-01-08
Labeling
ACETAZOLAMIDE 2026-01-08
Labeling
ACETAZOLAMIDE 2026-01-08
Labeling
METOLAZONE 2026-01-07
Manufacturing (CMC)
VARENICLINE TARTRATE 2025-12-18
Labeling
ACETAZOLAMIDE 2025-11-25
Manufacturing (CMC)
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 40%
2 drugs
Gastroenterology 20%
1 drugs
Neurology 20%
1 drugs
Ophthalmology 20%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

BAUSCH specialty
Ophthalmology, Cardiovascular, Gastroenterology
Novartis big-pharma
Cardiovascular, Ophthalmology
VALIDUS PHARMS specialty
Cardiovascular, Gastroenterology, Neurology
UPJOHN big-pharma
Neurology, Cardiovascular, Ophthalmology
WARNER CHILCOTT LLC specialty
Cardiovascular, Neurology, Gastroenterology